REQUEST A DEMO
Total
USD $0.00
Search more companies

Riviera Biotek OOO (Ривьера Биотек ООО) (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Riviera Biotek OOO Profile Updated: October 16, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Riviera Biotek OOO (Ривьера Биотек ООО) is based in Russia, with the head office in Krasnodar. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on May 08, 2008. It currently has a total number of 18 (2022) employees. In 2025, the company reported a net sales revenue increase of 43.76%. Its’ total assets recorded a growth of 38.33%. The enterprise’s net profit margin increased by 0.53% in 2025.

Headquarters
Onezhskaya, 64, 6
Krasnodar; Krasnodar Krai; Postal Code: 350059

Contact Details: Purchase the Riviera Biotek OOO (Ривьера Биотек ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Riviera Biotek OOO (Ривьера Биотек ООО) report to view the information.
Registered Capital:
Purchase the Riviera Biotek OOO (Ривьера Биотек ООО) report to view the information.
Financial Auditors:
Purchase the Riviera Biotek OOO (Ривьера Биотек ООО) report to view the information.
Incorporation Date:
May 08, 2008
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
95%
Purchase this report to view the information.
5%
Company Performance
Financial values in the chart are available after Riviera Biotek OOO (Ривьера Биотек ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
43.76%▲
Total Operating Revenue
43.76%▲
Operating Profit
63%▲
Net Profit/Loss for the Period
50.35%▲
Total Assets
38.33%▲
Total Equity
35.23%▲
Operating Profit Margin
2.01%▲
Net Profit Margin
0.53%▲
Return on Equity (ROE)
2.62%▲
Quick Ratio
0.3%▲
Cash Ratio
-0.05%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?